Helsinki-based Valo Therapeutics bags €19M to transform cancer treatment and…
Helsinki-based Valo Therapeutics Oy, a developer of novel immunotherapies in cancer and infectious disease, has secured €19M in funding, part of which was raised in Europe and Australia.